glp 1 who should take GLP-1 medications may not work well for a significant portion of the population, a Stanford Medicine researcher and her colleagues found. Genetic testing could help patients get on the right drugs faster who should not take glp-1

weeks 1-16 on tirzepatide Semaglutide GI rate / 44.2% nausea, 31.5% diarrhea, 23.4% constipation in STEP-1 (N=1,961) Tirzepatide GI rate / approximately 80% of patients on 15 mg reported at least one GI effect in SURMOUNT-1 (N=2,539) First-line fix / avoid high-sulfur foods (eggs, garlic, cruciferous vegetables) on injection days Medication option / simethicone (Gas-X, 125 mg) or bismuth subsalicylate (Pepto-Bismol) may reduce odor and frequency Serious warning / new right-upper-quadrant pain plus burping may signal gallbladder disease, not routine GI upset Discontinuation / roughly 7% of semaglutide 2.4 mg patients stopped due to GI side effects in STEP-1 Dose strategy / slower titration reduces GI burden without meaningfully reducing weight loss outcomes What Causes Sulfur Burps on GLP-1 Drugs GLP-1 receptor agonists slow gastric emptying as a deliberate pharmacological effect

Reference source not found

Let me break down who qualifies and how it works

Doctors recommend engaging in aerobic exercises like walking or cycling three times per week, plus strength training activities like weightlifting or bodyweight exercises at least twice a week

Mindful eating, or taking your time while eating, may also be beneficial as well

Proteins that were upregulated by GLP-1GIPLani (cluster 2) were enriched in functions related to cell division, DNA binding, transcriptional regulation and mRNA metabolism, whereas proteins that were downregulated by GLP-1GIPLani (cluster 4) were associated with mitochondrial inner membrane components, oxidative phosphorylation, tricarboxylic acid cycle, NAD-related processes and protein biosynthesis (Extended Data Fig